Impact of genetic polymorphism in the β₂-receptor gene on risk of severe hypoglycemia in patients with type 1 diabetes

Impact of genetic polymorphism in the β₂-receptor gene on risk of severe hypoglycemia in... Abstract Context and Objective Severe hypoglycemic events are unevenly distributed in subjects with type 1 diabetes making a genetic influence probable. The adrenergic beta-2-receptor gene (ADRB2) has several common polymorphisms of which the Arg16 allele is associated with receptor down-regulation and reduced agonist-mediated endogenous glucose production. We tested the hypothesis that the Arg16 variant is associated with severe hypoglycaemia. Method A cohort of 311 subjects with type 1 diabetes reported severe hypoglycemic events retrospectively in a validated questionnaire. The subjects were characterized by diabetes history, state of hypoglycemia awareness (Clarke, Gold, and Hillerød methods), C-peptide status, hemoglobin A1c (HbA1c), and ADRB2 genotype. Results The ADRB2 Gly16Arg genotype distribution was in Hardy-Weinberg equilibrium. There was a difference in rate of severe hypoglycemia between all genotypes (P=0.01). Subjects homozygous for the Arg16 genotype (AA, n=60) had a relative rate of severe hypoglycemia of 2.2 (CI95 1.3-3.6) compared to subjects homozygous for the Gly16 genotype (GG, n=116) (P=0.002). Among subjects with impaired awareness or unawareness (n=175) those with the AA genotype (n=33) had a relative rate of severe hypoglycemia of 3.2 (CI95 1.7-6.0) compared to subjects with the GG genotype (n=58) (P<0.000). Genotype was not associated with state of hypoglycemia awareness per se as assessed by any of three classification methods. The difference was not explained by other risk factors (duration of diabetes, HbA1c, C-peptide). Conclusions Genetic polymorphism in the beta-2-receptor gene is associated with risk of severe hypoglycemia in individuals with type 1 diabetes, especially in those with impaired hypoglycemia awareness. Copyright © 2018 Endocrine Society http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Endocrinology and Metabolism Oxford University Press

Impact of genetic polymorphism in the β₂-receptor gene on risk of severe hypoglycemia in patients with type 1 diabetes

Loading next page...
 
/lp/ou_press/impact-of-genetic-polymorphism-in-the-receptor-gene-on-risk-of-severe-S5gqOPMAtj
Publisher
Endocrine Society
Copyright
Copyright © 2018 Endocrine Society
ISSN
0021-972X
eISSN
1945-7197
D.O.I.
10.1210/jc.2017-02739
Publisher site
See Article on Publisher Site

Abstract

Abstract Context and Objective Severe hypoglycemic events are unevenly distributed in subjects with type 1 diabetes making a genetic influence probable. The adrenergic beta-2-receptor gene (ADRB2) has several common polymorphisms of which the Arg16 allele is associated with receptor down-regulation and reduced agonist-mediated endogenous glucose production. We tested the hypothesis that the Arg16 variant is associated with severe hypoglycaemia. Method A cohort of 311 subjects with type 1 diabetes reported severe hypoglycemic events retrospectively in a validated questionnaire. The subjects were characterized by diabetes history, state of hypoglycemia awareness (Clarke, Gold, and Hillerød methods), C-peptide status, hemoglobin A1c (HbA1c), and ADRB2 genotype. Results The ADRB2 Gly16Arg genotype distribution was in Hardy-Weinberg equilibrium. There was a difference in rate of severe hypoglycemia between all genotypes (P=0.01). Subjects homozygous for the Arg16 genotype (AA, n=60) had a relative rate of severe hypoglycemia of 2.2 (CI95 1.3-3.6) compared to subjects homozygous for the Gly16 genotype (GG, n=116) (P=0.002). Among subjects with impaired awareness or unawareness (n=175) those with the AA genotype (n=33) had a relative rate of severe hypoglycemia of 3.2 (CI95 1.7-6.0) compared to subjects with the GG genotype (n=58) (P<0.000). Genotype was not associated with state of hypoglycemia awareness per se as assessed by any of three classification methods. The difference was not explained by other risk factors (duration of diabetes, HbA1c, C-peptide). Conclusions Genetic polymorphism in the beta-2-receptor gene is associated with risk of severe hypoglycemia in individuals with type 1 diabetes, especially in those with impaired hypoglycemia awareness. Copyright © 2018 Endocrine Society

Journal

Journal of Clinical Endocrinology and MetabolismOxford University Press

Published: May 10, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off